Ad
AVXL - Anavex Life Sciences Stock Trading
About | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Anavex is a pharmaceutical company engaged in the development of drug candidates.
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
| Last: | $9.15 |
|---|---|
| Change Percent: | -0.43% |
| Open: | $9.28 |
| Close: | $9.15 |
| High: | $10.17 |
| Low: | $8.91 |
| Volume: | 3,978,066 |
| Last Trade Date Time: | 06/09/2023 03:00:00 am |
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
-
2023-06-06 21:00:06 ET Summary Blarcamesine, a sigma-1 receptor agonist, may be a more effective antioxidant than Aricept and galantamine in treating Alzheimer's disease. If granted accelerated approval by the FDA, Anavex's stock value is expected to rise significantly. Anavex...
-
NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders ...
Message Board Posts | Anavex Life Sciences Corp. (NASDAQ:AVXL)
| Subject | By | Source | When |
|---|---|---|---|
| Alzheimer's Association International Conference | georgejjl | investorshub | 06/10/2023 4:15:31 AM |
| Sorry for falling on that quick P&D scheme. | jav0033 | investorshub | 06/10/2023 3:42:03 AM |
| Expect complete Anavex Phase 2b/3 Alzheimer's trial results | georgejjl | investorshub | 06/10/2023 3:38:33 AM |
| My reference to a "liquidity event" was related | kevindenver | investorshub | 06/10/2023 2:55:53 AM |
| No, the reality is --- some people bought | Anshu2 | investorshub | 06/10/2023 2:53:50 AM |
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
